The results of a Phase 1 trial of autologous mitochondrial transplantation for the treatment of acute ischemic stroke during mechanical thrombectomy are presented. Standardized methods were used to isolate viable autologous mitochondria in the acute clinical setting, allowing for timely transplantation within the ischemic window. No significant adverse events were observed with the endovascular approach during reperfusion therapy. Safety outcomes in study participants were comparable to those of matched controls who did not undergo transplantation. This study represents the first use of mitochondrial transplantation in the human brain, highlighting specific logistical challenges related to the acute clinical setting, such as limited tissue samples and constrained time for isolation and transplantation. We also review the opportunities and challenges associated with further clinical translation of mitochondrial transplantation in the context of acute cerebral ischemia and beyond.
GBD 2019 Stroke Collaborators.
Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the global burden of disease study 2019. Lancet Neurol2021;
20: 795–820.
2.
ZhangMLiuQMengH, et al.
Ischemia-reperfusion injury: molecular mechanisms and therapeutic targets. Signal Transduct Target Ther2024;
9: 12.
3.
PanconesiRWidmerJCarvalhoMF, et al.
Mitochondria and ischemia reperfusion injury. Curr Opin Organ Transplant2022;
27: 434–445.
4.
ErenFYilmazSE.Neuroprotective approach in acute ischemic stroke: a systematic review of clinical and experimental studies. Brain Circ2022;
8: 172–179.
5.
GhozySRedaAVarneyJ, et al.
Neuroprotection in acute ischemic stroke: a battle against the biology of nature. Front Neurol2022;
13: 870141.
6.
StocchettiNTacconeFSCiterioG, et al.
Neuroprotection in acute brain injury: an up-to-date review. Crit Care2015;
19: 186.
7.
RehmanSNadeemAAkramU, et al.
Molecular mechanisms of ischemic stroke: a review integrating clinical imaging and therapeutic perspectives. Biomedicines2024;
12: 812.
8.
PowersWJRabinsteinAAAckersonT, et al.
Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American heart association/American stroke association. Stroke2019;
50: e344–e418.
9.
EmaniSMPiekarskiBLHarrildD, et al.
Autologous mitochondrial transplantation for dysfunction after ischemia-reperfusion injury. J Thorac Cardiovasc Surg2017;
154: 286–289.
10.
MasuzawaABlackKMPacakCA, et al.
Transplantation of autologously derived mitochondria protects the heart from ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol2013;
304: H966–82.
11.
WalkerMFedericoESancakY, et al.
Mitochondrial transplantation in ischemic stroke: insights from a first-in-human brain trial. Curr Transpl Rep2024;
11: 53–62.
12.
HayakawaKEspositoEWangX, et al.
Transfer of mitochondria from astrocytes to neurons after stroke. Nature2016;
535: 551–555.
13.
Al Amir DacheZOtandaultATanosR, et al.
Blood contains circulating cell-free respiratory competent mitochondria. FASEB J2020;
34: 3616–3630.
14.
SongXHuWYuH, et al.
Existence of circulating mitochondria in human and animal peripheral blood. Int J Mol Sci2020;
21: 2122.
15.
Ramirez-BarbieriGMoskowitzovaKShinB, et al.
Alloreactivity and allorecognition of syngeneic and allogeneic mitochondria. Mitochondrion2019;
46: 103–115.
16.
NoratPSokolowskiJDGorickCM, et al.
Intraarterial transplantation of mitochondria after ischemic stroke reduces cerebral infarction. Stroke Vasc Interv Neurol2023;
3. doi:10.1161/svin.122.000644.
17.
NoratPSoldozySSokolowskiJD, et al.
Mitochondrial dysfunction in neurological disorders: exploring mitochondrial transplantation. NPJ Regen Med2020;
5: 22.
EldridgeSMChanCLCampbellMJ, et al.
CONSORT 2010 statement: extension to randomised pilot and feasibility trials. Pilot Feasibility Stud2016;
2: 64.
20.
BarberPADemchukAMZhangJ, et al.
Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS study group. Alberta stroke programme early CT score. Lancet2000;
355: 1670–1674.
21.
McCullyJPrebleJKondoH, et al.
Quality control parameters for mitochondria transplant in cardiac tissue. JSM Biochemistry and Molecular Biology2014;
2: 1008.
22.
PrebleJMPacakCAKondoH, et al.
Rapid isolation and purification of mitochondria for transplantation by tissue dissociation and differential filtration. J Vis Exp2014; e51682.
23.
McCullyJDCowanDBEmaniSM, et al.
Mitochondrial transplantation: from animal models to clinical use in humans. Mitochondrion2017;
34: 127–134.
ShinBSaeedMYEschJJ, et al.
A novel biological strategy for myocardial protection by intracoronary delivery of mitochondria: Safety and efficacy. JACC Basic Transl Sci2019;
4: 871–888.
26.
EmaniSMMcCullyJD.Mitochondrial transplantation: applications for pediatric patients with congenital heart disease. Transl Pediatr2018;
7: 169–175.
27.
McCullyJDLevitskySDel NidoPJ, et al.
Mitochondrial transplantation for therapeutic use. Clin Transl Med2016;
5: 16.
28.
WechslerMB.Studies on oxidative phosphorylation and ATPase activity of fresh and frozen brain mitochondria. Arch Biochem Biophys1961;
95: 494–498.
29.
NukalaVNSinghINDavisLM, et al.
Cryopreservation of brain mitochondria: a novel methodology for functional studies. J Neurosci Methods2006;
152: 48–54.
30.
SpinazziMCasarinAPertegatoV, et al.
Assessment of mitochondrial respiratory chain enzymatic activities on tissues and cultured cells. Nat Protoc2012;
7: 1235–1246.
31.
NottolaSAAlbaniECoticchioG, et al.
Freeze/thaw stress induces organelle remodeling and membrane recycling in cryopreserved human mature oocytes. J Assist Reprod Genet2016;
33: 1559–1570.
32.
PowersWJRabinsteinAAAckersonT, et al.
2018 Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke2018;
49: e46–e110.
33.
ZhuX-HQiaoHDuF, et al.
Quantitative imaging of energy expenditure in human brain. Neuroimage2012;
60: 2107–2117.
34.
AttwellDLaughlinSB.An energy budget for signaling in the grey matter of the brain. J Cereb Blood Flow Metab2001;
21: 1133–1145.
FoxPTRaichleMEMintunMA, et al.
Nonoxidative glucose consumption during focal physiologic neural activity. Science1988;
241: 462–464.
37.
FromAHZimmerSDMichurskiSP, et al.
Regulation of the oxidative phosphorylation rate in the intact cell. Biochemistry1990;
29: 3731–3743.
38.
RolfeDFBrownGC.Cellular energy utilization and molecular origin of standard metabolic rate in mammals. Physiol Rev1997;
77: 731–758.
39.
VaishnaviSNVlassenkoAGRundleMM, et al.
Regional aerobic glycolysis in the human brain. Proc Natl Acad Sci U S A2010;
107: 17757–17762.
40.
EguchiYShimizuSTsujimotoY.Intracellular ATP levels determine cell death fate by apoptosis or necrosis. Cancer Res1997;
57: 1835–1840.
41.
VergaraRCJaramillo-RiveriSLuarteA, et al.
The energy homeostasis principle: neuronal energy regulation drives local network dynamics generating behavior. Front Comput Neurosci2019;
13: 49.
42.
MisgeldTSchwarzTL.Mitostasis in neurons: maintaining mitochondria in an extended cellular architecture. Neuron2017;
96: 651–666.
43.
AzevedoFACCarvalhoLRBGrinbergLT, et al.
Equal numbers of neuronal and nonneuronal cells make the human brain an isometrically scaled-up primate brain. J Comp Neurol2009;
513: 532–541.
44.
PelvigDPPakkenbergHStarkAK, et al.
Neocortical glial cell numbers in human brains. Neurobiol Aging2008;
29: 1754–1762.
45.
BangOYGoyalMLiebeskindDS.Collateral circulation in ischemic stroke: assessment tools and therapeutic strategies. Stroke2015;
46: 3302–3309.
46.
McCullyJDCowanDBPacakCA, et al.
Injection of isolated mitochondria during early reperfusion for cardioprotection. Am J Physiol Heart Circ Physiol2009;
296: H94–H105.
47.
ShinBCowanDBEmaniSM, et al.
Mitochondrial transplantation in myocardial ischemia and reperfusion injury. Adv Exp Med Biol2017;
982: 595–619.
48.
KarlssonJOGregersenMRefsumH.Visipaque is isotonic to human and rat blood plasma. Acta Radiol Suppl1995;
399: 39–42.
49.
EivindvikKSjogrenCE.Physicochemical properties of iodixanol. Acta Radiol Suppl1995;
399: 32–38.
50.
FordTGrahamJRickwoodD.Iodixanol: a nonionic iso-osmotic centrifugation medium for the formation of self-generated gradients. Anal Biochem1994;
220: 360–366.
51.
GrahamJFordTRickwoodD.The preparation of subcellular organelles from mouse liver in self-generated gradients of iodixanol. Anal Biochem1994;
220: 367–373.
52.
SpencerCMGoaKL.Iodixanol. A review of its pharmacodynamic and pharmacokinetic properties and diagnostic use as an x-ray contrast medium. Drugs1996;
52: 899–927.
53.
FountaineHHarnishPAndrewE, et al.
Safety, tolerance, and pharmacokinetics of iodixanol injection, a nonionic, isosmolar, hexa-iodinated contrast agent. Acad Radiol1996;
3 Suppl 3: S475–84.
54.
SunJLamCChristieL, et al.
Risk factors of hemorrhagic transformation in acute ischaemic stroke: a systematic review and meta-analysis. Front Neurol2023;
14: 1079205.
55.
YangMPanYLiZ, et al.
Platelet count predicts adverse clinical outcomes after ischemic stroke or TIA: subgroup analysis of CNSR II. Front Neurol2019;
10: 370.
56.
ŽdraljevićMPekmezovićTStanarčevićP, et al.
Influence of thrombocytopenia on the outcome of mechanical thrombectomy in patients with acute ischemic stroke. J Stroke Cerebrovasc Dis2022;
31: 106240.
57.
MönchSBoeckh-BehrensTKreiserK, et al.
Thrombocytopenia and declines in platelet counts: predictors of mortality and outcome after mechanical thrombectomy. J Neurol2019;
266: 1588–1595.
58.
TorunoMAAl-JanabiOMGhozyS, et al.
Outcomes of mechanical thrombectomy in patients with acute ischemic stroke and thrombocytopenia: systematic review and meta-analysis. J Neurol2024;
271: 4383–4391.
59.
HuberTKleineJFKaesmacherJ, et al.
Blood leukocytes as prognostic parameter in stroke thrombectomy. Cerebrovasc Dis2016;
42: 32–40.
60.
TarkanyiGKaradiZNSzaboZ, et al.
Relationship between leukocyte counts and large vessel occlusion in acute ischemic stroke. BMC Neurol2020;
20: 440.
61.
VoTPKristiansenMHHasselbalchHC, et al.
Elevated white blood cell counts in ischemic stroke patients are associated with increased mortality and new vascular events. Front Neurol2023;
14: 1232557.
62.
SemeranoALaredoCZhaoY, et al.
Leukocytes, collateral circulation, and reperfusion in ischemic stroke patients treated with mechanical thrombectomy. Stroke2019;
50: 3456–3464.
63.
D'ErasmoEPisaniDRomagnoliS, et al.
Acute serum calcium changes in transient ischemic attack and cerebral infarction. J Med1998;
29: 331–337.
64.
WuCLiXLiJ, et al.
Association between serum calcium and prognosis in patients with acute ischemic stroke in ICU: analysis of the MIMIC-IV database. BMC Anesthesiol2024;
24: 139.
65.
ZhangJ-FMengXJingJ, et al.
Serum calcium and long-term outcome after ischemic stroke: results from the China national stroke registry III. Atherosclerosis2021;
325: 24–29.
66.
OvbiageleBStarkmanSTealP, VISTA Investigatorset al.
Serum calcium as prognosticator in ischemic stroke. Stroke2008;
39: 2231–2236.
67.
DiproseWKSutherlandLJWangMTM, et al.
Contrast-associated acute kidney injury in endovascular thrombectomy patients with and without baseline renal impairment. Stroke2019;
50: 3527–3531.
68.
WangRXieZLiB, et al.
Renal impairment and the prognosis of endovascular thrombectomy: a meta-analysis and systematic review. Ther Adv Neurol Disord2022;
15: 17562864221083620.
69.
SutherlandLJDiproseWKWangMTM, et al.
Chronic kidney disease and outcome following endovascular thrombectomy for acute ischemic stroke. J Stroke Cerebrovasc Dis2020;
29: 104665.
70.
PanXZhouFShenR, et al.
Influence of renal function on stroke outcome after mechanical thrombectomy: a prospective cohort study. BMC Neurol2020;
20: 134.
71.
YamamotoYYamamotoNKanematsuY, et al.
High white blood cell count is a risk factor for contrast-induced nephropathy following mechanical thrombectomy for acute ischemic stroke. Cerebrovasc Dis Extra2020;
10: 59–65.
72.
HeinzeMSchellMNägeleFL, et al.
Kidney dysfunction predicts 90 days mortality after stroke thrombectomy independent of cardiovascular risk factors and chronic kidney disease. Eur Stroke J2024;
9: 424–431.
73.
ChristensenHBoysenG.C-reactive protein and white blood cell count increases in the first 24 hours after acute stroke. Cerebrovasc Dis2004;
18: 214–219.
74.
DongFWangXLiJ, et al.
Causal relationship between lactate dehydrogenase and risk of developing ischemic stroke: a mendelian randomized study. Brain Behav2024;
14: e3352.
75.
IadecolaCAnratherJ.The immunology of stroke: from mechanisms to translation. Nat Med2011;
17: 796–808.
76.
CaoWSongYBaiX, et al.
Systemic-inflammatory indices and clinical outcomes in patients with anterior circulation acute ischemic stroke undergoing successful endovascular thrombectomy. Heliyon2024;
10: e31122.
77.
MereutaOMAbbasiMFitzgeraldS, et al.
Histological evaluation of acute ischemic stroke thrombi may indicate the occurrence of vessel wall injury during mechanical thrombectomy. J Neurointerv Surg2022;
14: 356–361.
78.
BradfordMM.A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem1976;
72: 248–254.
79.
Garcia-CazarinMLSniderNNAndradeFH.Mitochondrial isolation from skeletal muscle. J Vis Exp2011; doi:10.3791/2452.
80.
KielkopfCLBauerWUrbatschIL.Bradford assay for determining protein concentration. Cold Spring Harb Protoc2020;
2020: 102269.
81.
FrezzaCCipolatSScorranoL.Organelle isolation: functional mitochondria from mouse liver, muscle and cultured fibroblasts. Nat Protoc2007;
2: 287–295.
82.
Fernández-VizarraEFerrínGPérez-MartosA, et al.
Isolation of mitochondria for biogenetical studies: an update. Mitochondrion2010;
10: 253–262.
83.
JungMMunJY.Mitochondria and endoplasmic reticulum imaging by correlative light and volume electron microscopy. J Vis Exp2019; doi:10.3791/59750.
84.
DuranovaHValkovaVKnazickaZ, et al.
Mitochondria: a worthwhile object for ultrastructural qualitative characterization and quantification of cells at physiological and pathophysiological states using conventional transmission electron microscopy. Acta Histochem2020;
122: 151646.
85.
ZhangH-XDuG-HZhangJ-T.Assay of mitochondrial functions by resazurin in vitro. Acta Pharmacol Sin2004;
25: 385–389.
O'BrienJWilsonIOrtonT, et al.
Investigation of the alamar blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. Eur J Biochem2000;
267: 5421–5426.
88.
HaukoosJSLewisRJ.Advanced statistics: bootstrapping confidence intervals for statistics with ‘difficult’ distributions. Acad Emerg Med2005;
12: 360–365.
89.
EfronBNarasimhanB.The automatic construction of bootstrap confidence intervals. J Comput Graph Stat2020;
29: 608–619.
90.
AdamsHPJrBendixenBHKappelleLJ, et al.
Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of org 10172 in acute stroke treatment. Stroke1993;
24: 35–41.
91.
ZaidatOOYooAJKhatriP, STIR Thrombolysis in Cerebral Infarction (TICI) Task Forceet al.
Recommendations on angiographic revascularization grading standards for acute ischemic stroke: a consensus statement. Stroke2013;
44: 2650–2663.
92.
DrewBLeeuwenburghC.Method for measuring ATP production in isolated mitochondria: ATP production in brain and liver mitochondria of fischer-344 rats with age and caloric restriction. Am J Physiol Regul Integr Comp Physiol2003;
285: R1259–67.
93.
YatsuFMLeeL-WLiaoC-L.Energy metabolism during brain ischemia: stability during reversible and irreversible damage. Stroke1975;
6: 678–683.
94.
PhillisJWO'ReganMHEstevezAY, et al.
Cerebral energy metabolism during severe ischemia of varying duration and following reperfusion. J Neurochem1996;
67: 1525–1531.
95.
MandevilleETBuchanAMTiedtS.Not open and shut: complex and prolonged blood-brain barrier responses after stroke. J Cereb Blood Flow Metab2024;
44: 446–448.
96.
XueSZhouXYangZ-H, et al.
Stroke-induced damage on the blood-brain barrier. Front Neurol2023;
14: 1248970.
97.
JiangXAndjelkovicAVZhuL, et al.
Blood-brain barrier dysfunction and recovery after ischemic stroke. Prog Neurobiol2018;
163-164: 144–171.
98.
Ali PourPKenneyMCKheradvarA.Bioenergetics consequences of mitochondrial transplantation in cardiomyocytes. J Am Heart Assoc2020;
9: e014501.
99.
PangY-LFangS-YChengT-T, et al.
Viable allogeneic mitochondria transplantation improves gas exchange and alveolar-capillary permeability in rats with endotoxin-induced acute lung injuries. Int J Med Sci2022;
19: 1036–1046.
100.
JacobyEBar-YosefOGruberN, et al.
Mitochondrial augmentation of hematopoietic stem cells in children with single large-scale mitochondrial DNA deletion syndromes. Sci Transl Med2022;
14: eabo3724.
101.
NakaiRVarnumSFieldRL, et al.
Mitochondria transfer-based therapies reduce the morbidity and mortality of leigh syndrome. Nat Metab2024;
6: 1886–1896.
102.
JacobyEBen Yakir-BlumkinMBlumenfeld-KanS, et al.
Mitochondrial augmentation of CD34+ cells from healthy donors and patients with mitochondrial DNA disorders confers functional benefit. NPJ Regen Med2021;
6: 58.
103.
BorcherdingNBrestoffJR.The power and potential of mitochondria transfer. Nature2023;
623: 283–291.
